Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer
about
Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and ImagingA review of clinical effects associated with metabolic syndrome and exercise in prostate cancer patientsA Class of Semiparametric Mixture Cure Survival Models with Dependent Censoring.Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years' follow upRole of serum cholesterol and statin use in the risk of prostate cancer detection and tumor aggressiveness.Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort.Cholesterol and prostate cancer risk: a long-term prospective cohort study.Serum lipid profiles: novel biomarkers predicting advanced prostate cancer in patients receiving radical prostatectomy.Serum total and HDL cholesterol and risk of prostate cancerSerum lipid profiles and cancer risk in the context of obesity: four meta-analyses.Transit of hormonal and EGF receptor-dependent signals through cholesterol-rich membranesCholesterol, statins and cancer.New developments in medulloblastoma treatment: the potential of a cyclopamine-lovastatin combination.Mechanistic Study of Inhibitory Effects of Atorvastatin and Docetaxel in Combination on Prostate Cancer.Association between gallbladder stone disease and prostate cancer: A nationwide population-based study.Hypercholesterolemia Is Associated with a Shorter Time to Castration-Resistant Prostate Cancer in Patients Who Have Undergone Androgen Deprivation TherapyLow-density lipoprotein cholesterol suppresses apoptosis in human multiple myeloma cells.Chinese red yeast rice inhibition of prostate tumor growth in SCID mice.Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells.The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence.Dietary oleic acid regulates hepatic lipogenesis through a liver X receptor-dependent signalingA Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer.Ezetimibe is an inhibitor of tumor angiogenesis.BMI and serum lipid parameters predict increasing risk and aggressive prostate cancer in Chinese people.Dietary fat and early-onset prostate cancer risk.Anti-Proliferation Effects of Garlic (Allium sativum L.) on the Progression of Benign Prostatic Hyperplasia.Blood lipid levels and prostate cancer risk; a cohort studyProstate cancer risk in the Swedish AMORIS study
P2860
Q28070244-BC6EE82D-8FF7-4233-B236-AA6B0E022EC5Q28076622-F0D0CDC6-2E9B-4A85-BF07-8BDDE698B5A4Q34060554-8E3E7385-F365-4CB3-B6C0-CF0737255592Q34133206-58FDF137-0278-4B59-9FBE-947236A3CE21Q34158413-0E6177A8-76AC-41BF-AD89-E432B2DE395EQ34418735-2411BB8A-408A-48D1-9DC7-4436BA093F22Q36106400-6B606375-6BC4-4E9F-85CB-7966D754F5DEQ36293122-BDE47E94-F943-4681-9C0C-A5338B2E27D1Q36407365-0B22714F-AF44-4BCC-918C-C4DE53E6EB9BQ36584255-C4801886-55F5-46FF-9DE2-A25542039BF4Q36686183-361ED6F7-8D23-4754-8C8F-2E8449CF0D01Q36717492-2FA56935-46EB-43B0-928B-5671FD0DB8ABQ37071188-FC3E4791-16DF-4F75-A6F6-705F0D86DFDCQ37547305-A8CCC7E0-058B-46D0-AF8E-D90E9EF16967Q37665683-C98317C4-D6EC-4C0E-90AE-EECE291B2EA5Q38414609-DA3C809D-D7DD-4991-A479-31893B16BAFFQ39549404-42CC3BAA-381B-4776-A9FE-E842C21DFB6FQ39600769-9D8369BF-A07D-4623-8A42-7C3C47EE2125Q39733982-65D28624-7FB8-4CC8-9E08-083CC7DE6A62Q40649810-FC7B5C25-7904-46DF-B166-F23FCF173F25Q41090217-9A555CDF-5D1E-41E2-950F-9CC09DF1380CQ41460209-E35505BD-56E4-4381-B5EB-1DD949FF6EB1Q42045919-F6B8E4AE-DC55-40B8-B0AB-60A787499414Q42371605-C632FBA5-ED63-4ADC-A165-325E2D8BF688Q43457233-7A476F43-897B-4AA7-B1EE-A00E2C73D299Q53090197-180A063E-EC91-4A7A-BD83-4DBD2566767FQ57307183-67676314-1ABF-4F55-A8FC-59B835C49CACQ58813397-135832E5-E30C-4234-871C-9637FB35A808
P2860
Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer
description
im April 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 12 April 2006
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2006
@uk
name
Self-reported history of hyper ...... nd the risk of prostate cancer
@en
Self-reported history of hyper ...... nd the risk of prostate cancer
@nl
type
label
Self-reported history of hyper ...... nd the risk of prostate cancer
@en
Self-reported history of hyper ...... nd the risk of prostate cancer
@nl
prefLabel
Self-reported history of hyper ...... nd the risk of prostate cancer
@en
Self-reported history of hyper ...... nd the risk of prostate cancer
@nl
P2093
P2860
P50
P356
P1433
P1476
Self-reported history of hyper ...... nd the risk of prostate cancer
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDL080
P577
2006-04-12T00:00:00Z